AngioDynamics (ANGO) swung to a profit in the fourth quarter from a loss last year, helped by last year’s reserves for legal matters and Acculis recall. However, the medical device maker’s adjusted earnings and revenue came in below Street’s expectations. The company remained cautious as it set its full-year 2019 guidance below analysts’ view. With … Continue reading AngioDynamics misses Street consensus, shares dip